Also in this playlist...
This transcript is automatically generated
-- medical game changer.
The discovery of a rare gene mutation affecting cholesterol.
Is sparking hopes of approach prescription drug that could prevent prevent heart attacks.
And it's also igniting a race for pharmaceutical companies to be the first offered the drug with more on this doctor -- Campbell cardiologists.
Doctor Campbell thanks for coming on the show this is fascinating to made because.
Frankly I think it means I can eat anything I want to you but here's what's going -- pharma companies out there racing.
To develop this drug which sounds like it's going to be really expensive.
Tell us how it would work.
You know this drug is a game changer we know that cholesterol was one of the most important risk factors for heart disease.
For every 1% you lower your cholesterol number you lower your risk of cardiac death by 1%.
This new drug is an injectable substance that you get maybe once or twice a month and it pushes your cholesterol numbers down to.
The lower ranges than we have ever seen and human beings before.
Well let's give a little background here -- an interesting story behind this is there a couple of people.
Out there with this mutated gene and they have cholesterol levels of 1415.
Unheard of levels if we can mimic that with the drug.
That would help so many people in this country I mean the possibilities for this are amazing right.
If we can modify risk factors such as high cholesterol we can impact disease.
And particularly with the rising cost of health care if we're able -- Prevent heart attacks and the cost associated with that it could be a game changer in health care economics.
However as you mentioned the other side of this -- these drugs may be very very expensive.
Because they're expensive to make in fact.
You think -- that the health care companies out there will cover.
This drug is it likely that they may not want to pick up the tab for this.
I think that is going to be -- -- at times to get insurance companies to cover this.
I spent a great deal of my time arguing with insurance companies about paying for certain therapies for my patients are around it's going to be very get absolutely.
And it's going to be very expensive but if it's a game changer in May in the long run.
Still the reason error reporting on this today is that we there are already testing this drug and finding amazing results in the tests alone.
How far away might we be from seeing this energy use is a drug that anybody could get -- You know the FDA approval process is quite a long process so I think we're still talking.
Twelve to eighteen months but we have to complete the clinical trials we have to present that data to the FDA.
And let them decide if it's safe and and a good efficacy rate.
On to help our patients.
What companies are what firm -- out there are likely to be first out of the gate with the drug.
That companies that are pretty far advanced right now -- and -- -- -- feet and Pfizer in fact.
One of these companies has built plants offshore that are ready to start making this drug and they've invested a lot of money.
In thinks that you know thinking that they're gonna have a huge return down the line of good his doctor Campbell thanks for bringing it to us we appreciate it thanks.
Thank you for having me tonight.
Filter by section